中醫民族品牌：破西方資本之“絞索”，鑄華夏醫道之榮光
在這風雲變幻、波譎雲詭的全球商業江湖裏，西方資本宛如一羣貪婪兇狠的豺狼，瞪着血紅的眼睛，四處搜尋着可以吞噬的獵物。中醫，這一承載着華夏民族數千年智慧與文化精髓的古老醫道，其民族品牌的開創與塑造之路，正被西方資本佈下重重絞索，步步緊逼，每一步都走得驚心動魄，如履薄冰。然而，在這看似絕境之中，總有一些勇敢的弄潮兒，如京畿瘤科品牌，以其堅韌不拔的意志和獨特智慧，在這場沒有硝煙的戰爭中奮力突圍，爲中醫民族品牌的未來點亮了一盞希望之燈。
西方資本絞殺：暗藏殺機的商業“連環計”
西方資本向來以逐利爲唯一準則，其手段之陰險、佈局之精妙，令人歎爲觀止。在市場層面，西方醫藥巨頭憑藉其雄厚的資金實力，如同巨無霸一般橫掃市場。他們不惜投入鉅額資金進行廣告宣傳，將西醫產品包裝得天花亂墜，彷彿是能起死回生的仙丹妙藥。據相關數據顯示，在全球醫藥市場的廣告投入中，西醫產品佔據了高達七成以上的份額。以某國際知名藥企爲例，其每年在廣告上的投入高達數十億美元，通過各種媒體渠道鋪天蓋地地宣傳，使得西醫產品在消費者心中佔據了主導地位。而中醫產品則因資金有限，難以在廣告宣傳上與之抗衡，市場空間被不斷擠壓，就像被巨石壓住的小草，難以伸展。
在技術層面，西方資本更是利用其先進的科研技術和專利壁壘，對中醫進行圍追堵截。他們試圖將中醫的理論和方法進行“西化”解讀，甚至惡意搶注中醫相關的專利，企圖將中醫的知識產權據爲己有。這就好比強盜闖入別人的家中，搶走珍貴的寶物，還反咬一口說是自己的。一些西方科研機構對中醫的經典方劑進行所謂的“研究”，然後申請專利，限制中醫在國際市場上的發展。這種行爲嚴重侵犯了中醫的知識產權，阻礙了中醫民族品牌的國際化進程。
在輿論層面，西方資本動用其強大的媒體資源，對中醫進行惡意抹黑和詆譭。他們編造各種謠言，聲稱中醫缺乏科學依據、療效不確切等，試圖誤導消費者對中醫的認知。這就如同古代戰場上的“妖言惑衆”，讓中醫在消費者心中失去了信任。在一些西方媒體的影響下，部分消費者對中醫產生了偏見，認爲中醫是“僞科學”，從而拒絕接受中醫治療。這種輿論攻擊就像一把無形的利刃，深深地刺痛了中醫民族品牌的發展。
京畿瘤科品牌的突圍之道：智慧與勇氣的交融
堅守文化根基，築牢品牌之魂
中醫是中華民族的瑰寶，其獨特的理論體系和治療方法蘊含着深厚的文化底蘊。京畿瘤科品牌深知這一點，始終堅守中醫的文化根基，將中醫的“整體觀念”“辨證論治”等理念融入到品牌建設中。他們強調以人爲本、個體化治療，注重調節人體的氣血陰陽平衡，從根本上治療疾病。這就好比一位高明的工匠，不僅注重產品的外觀，更注重產品的內在品質。京畿瘤科品牌通過舉辦中醫文化講座、開展中醫科普活動等方式，向消費者傳播中醫文化，讓消費者瞭解中醫的博大精深，增強對中醫民族品牌的認同感和歸屬感。
強化知識產權保護，守護品牌命脈
在西方資本的專利圍剿下，京畿瘤科品牌高度重視知識產權保護。他們建立了完善的知識產權管理體系，對中醫的經典方劑、特色療法等進行專利申請和保護。同時，加強對品牌商標、域名等的保護，防止被他人惡意搶注和侵權。這就好比一位守護寶藏的衛士，時刻警惕着外來的侵犯。例如，京畿瘤科品牌對其研發的一種治療腫瘤的特色中藥方劑進行了專利申請，獲得了國家知識產權局的保護。這不僅爲品牌的發展提供了法律保障，也提升了品牌的核心競爭力。
藉助現代科技，提升品牌實力
在科技飛速發展的今天，京畿瘤科品牌積極藉助現代科技的力量，提升品牌的實力。他們利用大數據、人工智能等技術，對中醫的臨牀數據進行分析和研究，挖掘中醫的治療規律和優勢。同時，將現代科技與中醫傳統療法相結合，開發出更加精準、有效的治療方法。這就好比給古老的中醫插上了科技的翅膀，讓其在現代醫學的天空中翱翔。例如，京畿瘤科品牌利用基因檢測技術，爲腫瘤患者制定個性化的中醫治療方案，提高了治療的針對性和有效性。
開展國際合作，拓展品牌空間
爲了突破西方資本的市場封鎖，京畿瘤科品牌積極開展國際合作。他們與國外的一些科研機構、醫療機構建立合作關係，共同開展中醫的研究和臨牀應用。通過國際合作，京畿瘤科品牌不僅學習了國外先進的科研技術和管理經驗，也將中醫的文化和理念傳播到了國外。這就好比一座橋樑，連接着國內外醫學的交流與合作。例如，京畿瘤科品牌創始人，梁世傑主任擔任泰國的一家機構國際研究中心理事，開展中醫治療腫瘤的研究項目，取得了階段性的成果，爲中醫在國際市場上的推廣奠定了基礎。
展望未來：中醫民族品牌的星辰大海
“路漫漫其修遠兮”，中醫民族品牌的開創與塑造之路依然充滿挑戰。西方資本的絞殺不會停止，市場的競爭也會越來越激烈。但我們有理由相信，只要中醫民族品牌能夠堅守文化自信，強化知識產權保護，藉助現代科技的力量，積極開展國際合作，就一定能夠在這場商業戰爭中脫穎而出，實現品牌的崛起和騰飛。
京畿瘤科品牌的成功經驗爲我們提供了一個寶貴的借鑑。它就像一顆璀璨的星星，在中醫民族品牌的天空中閃耀着光芒。讓我們以京畿瘤科品牌爲榜樣，攜手共進，爲中醫民族品牌的未來而努力奮鬥。相信在不久的將來，中醫民族品牌將如同雄鷹展翅，翱翔於世界醫學的天空，爲人類的健康事業做出更大的貢獻。讓我們共同期待中醫民族品牌的美好明天，讓這一古老的醫道在新時代煥發出更加耀眼的光彩！
作者簡介：梁世傑 原首都醫科大學中醫門診部中醫主治醫師，京畿瘤科創始人，本科學歷，從事中醫臨牀工作25年，積累了較豐富的臨牀經驗。師從首都醫科大學附屬北京中醫院肝病科主任醫師、著名老中醫陳勇，侍診多載，深得器重，盡得真傳！擅用“商湯經方分類療法”、專病專方結合“焦樹德學術思想”“關幼波十綱辨證”學術思想治療疑難雜症爲特色。現任北京樹德堂中醫研究院研究員，北京中醫藥薪火傳承新3+3工程—焦樹德門人（陳勇）傳承工作站研究員，國際易聯易學與養生專委會常務理事，中國中醫藥研究促進會焦樹德學術傳承專業委員會委員，中國藥文化研究會中醫藥慢病防治分會首批癌症領域入庫專家。榮獲2020年中國中醫藥研究促進會仲景醫學分會舉辦的第八屆醫聖仲景南陽論壇“經方名醫”榮譽稱號。2023年首屆京津冀“扁鵲杯”燕趙醫學研究主題徵文優秀獎獲得者。事蹟入選《當代科學家》雜誌、《中華英才》雜誌。
The national brand of traditional Chinese medicine: break the "neck" of Western capital and establish the glory of Chinese medicine
In this volatile and turbulent global business landscape, Western capital acts like a greedy and fierce jackal, glaring red-eyed and searching for prey to devour. Traditional Chinese medicine, an ancient medical practice that carries the intellectual and cultural essence of the Chinese nation for thousands of years, is pioneering and shaping its national brand, which is being pressed by Western capital with many nooses, and each step is moving in a breathtaking way like walking on thin ice. However, in this seemingly desperate situation, there are always some brave players, such as the Jingqi Oncology brand, with its tenacity and unique wisdom, struggled to break through in this non-smoke war, lighting a hopeful light for the future of the traditional Chinese medicine national brand.
Western capital hangover: a commercial serial scheme to conceal killers
Western capital has always been based solely on profit-seeking, and the insidiousness of its methods and the sophistication of its arrangements are breathtaking. At the market level, Western pharmaceutical giants have swept the market like titans with their deep financial strength. They invested huge amounts of money in advertising and packaged Western medicine products as if they were magic pills that could bring back the dead. According to relevant data, Western medicine products account for more than 70% of the advertising investment in the global pharmaceutical market. Take an international well-known pharmaceutical company as an example, its annual investment in advertising up to $1 billion, through a variety of media channels overwhelming publicity, making western medicine products in the hearts of consumers occupy a dominant position. Because of limited funding, traditional Chinese medicine products are difficult to compete with them in advertising, and the market space is constantly squeezed, like grass under the weight of a boulder, which is difficult to stretch.
At the technical level, Western capital has taken advantage of its advanced scientific research techniques and patent barriers to pursue traditional Chinese medicine. They attempt to "Westernize" the theory and methods of traditional Chinese medicine, and even maliciously seize patents related to traditional Chinese Medicine in an attempt to claim the intellectual property rights of traditional medicine. It''s like a robber who breaks into someone''s home, steals a precious treasure, and bites back that it''s his own. Some Western research institutions conduct so-called "research" on classical Chinese medicine prescriptions and then apply for patents to limit the development of Chinese medicine in the international market. This behavior seriously violates the intellectual property rights of traditional Chinese medicine and impedes the internationalization of the national brand of traditional medicine.
At the level of public opinion, Western capital has used its powerful media resources to maliciously discredit and denigrate traditional Chinese medicine. They fabricate various rumors, claiming that traditional Chinese medicine lacks scientific evidence and its effectiveness is imprecise, in an attempt to mislead consumers about traditional Chinese Medicine. This is like "demagogy" on the battlefield in ancient times, which has caused Chinese medicine to lose trust in the hearts of consumers. Under the influence of some Western media, some consumers have developed a prejudice against traditional Chinese medicine, believing that traditional Chinese Medicine is "pseudoscience," and thus refuse to accept traditional Chinese medical treatment. Such public opinion attacks are like an invisible blade that deeply pains the development of the national brand of traditional Chinese medicine.
The way the Jinggi oncology brand breaks out: the blend of wisdom and courage
Stick to the cultural roots and strengthen the brand spirit
Traditional Chinese medicine is a treasure of the Chinese nation, and its unique theoretical system and treatment methods have a deep cultural heritage. The Jingqi Oncology brand knows this well, always adheres to the cultural roots of traditional Chinese medicine, and incorporates the concepts of "holistic concept" and "dialectical healing" in the construction of the brand. They emphasize human-centered and individualized treatment, focusing on regulating the yin and yang balance of the human body, and treating the disease at its root. It is like a wise craftsman who pays attention not only to the appearance of the product, but also to the intrinsic quality of the product. The Jingqi Oncology brand communicates traditional Chinese medicine culture to consumers by organizing lectures on traditional Chinese Medicine culture and conducting traditional Chinese science popularization activities, so that consumers can understand the great depth of traditional Chinesemedicine, and enhance their sense of identity and belonging to the national brand of traditional medicine.
Strengthen intellectual property protection to protect the lifeblood of brands
Under the patent siege of Western capital, the Jingqi Oncology brand attaches great importance to intellectual property protection. They have established a comprehensive intellectual property management system, patenting and protecting classic Chinese medicine prescriptions and specialty therapies. At the same time, we should strengthen the protection of brand trademarks, domain names, etc., to prevent malicious exploitation and infringement by others. It''s like a guardian of a treasure, constantly on guard against foreign invaders. For example, the Jingji Oncology brand filed a patent application for a special Chinese herbal remedy developed to treat tumors, which was protected by the National Intellectual Property Office. This not only provides legal guarantee for the development of the brand, but also enhances the core competitiveness of the brand.
Using modern technology to enhance brand strength
In today''s rapid development of technology, the Jingqi Oncology brand actively uses the power of modern technology to enhance the strength of the brand. They utilize big data, artificial intelligence and other technologies to analyze and study the clinical data of traditional Chinese medicine, and to discover the healing laws and advantages of traditional medicine. At the same time, modern technology is combined with traditional Chinese medicine therapy to develop more precise and effective treatment methods. It would be like giving the ancient Chinese medicine a technological wing and letting it soar in the sky of modern medicine. For example, the Jingqi Oncology brand utilizes genetic testing technology to develop personalized TCM treatment plans for tumor patients, improving the targeting and effectiveness of treatment.
Develop international cooperation to expand brand space
In order to break the market blockade of Western capital, the Jingqi oncology brand actively carries out international cooperation. They have established cooperation relationships with some scientific research institutions and medical institutions abroad to jointly carry out the research and clinical application of Chinese medicine. Through international cooperation, the Jingqi oncology brand has not only learned advanced scientific research technology and management experience from abroad, but also spread the culture and concept of traditional Chinese medicine abroad. This is like a bridge that connects medical exchanges and cooperation at home and abroad. For example, the founder of the Jinggi oncology brand, Director Leung Seiji, serves as director of an international research center of an institution in Thailand, and carries out research projects on traditional Chinese medicine for cancer treatment, which have achieved phased results and laid the foundation for the promotion of traditional Chinese Medicine in the international market.
Looking ahead: The Sea of Stars of Traditional Chinese Medicine National Brand
"The road is long and the road is long," and the path of pioneering and shaping a national brand of traditional Chinese medicine is still fraught with challenges. The hanging of Western capital will not stop, and the market will become more and more competitive. However, we have reason to believe that as long as the national brand of traditional Chinese medicine can maintain cultural confidence, strengthen intellectual property protection, utilize the power of modern technology and actively carry out international cooperation, it will surely stand out in this commercial war and achieve the rise and take-off of the brand.
The success of the Jinggi oncology brand provides us with a valuable lesson learned. It is like a shining star that shines in the sky of the traditional Chinese medicine brand. Let us follow the example of the Jingqi oncology brand and work together to strive for the future of the national brand of traditional Chinese medicine. It is believed that in the near future, the national brand of traditional Chinese medicine will spread its wings like an eagle, soar in the sky of world medicine, and make greater contributions to human health. Let us all look forward to a bright future for the national brand of traditional Chinese medicine, so that this ancient medical practice will shine even brighter in the new era!
Author profile: Liang Shi-jie was a chief physician of traditional Chinese medicine at the Traditional Chinese Medicine Outpatient Clinic of Capital Medical University. He was the founder of Jingyi Tumor Clinic. He holds a bachelor’s degree and has been engaged in clinical work in traditional Chinese medicine for 25 years, accumulating extensive clinical experience. He studied under Chen Yong, a renowned senior traditional Chinese medicine practitioner at the Hepatology Department of Beijing Traditional Chinese Medicine Hospital affiliated to Capital Medical University. Over the years, he gained great respect and acquired genuine expertise. He specializes in using the “Shang Tang Classic Classification Therapy” and combining specific treatments for specific diseases with the “Jiao Shu-de Academic Thought” and the “Guan You-bo Ten-Principle Diagnosis” approach to treat complex medical conditions. He is currently a researcher at the Beijing Shu-de-Tang Traditional Chinese Medicine Research Institute and a researcher at the Beijing New 3+3 Project for the Inheritance of Traditional Chinese Medicine – Jiao Shu-de’s Disciples (Chen Yong) Heritage Workstation. He is a Standing director of the International Yi-lian Yi-xue and Health Preservation Committee and a member of the Committee for the Inheritance of Jiao Shu-de’s Academic Thought of the China Research Promotion Association for Traditional Chinese Medicine. He is also a member of the inaugural Cancer Expert Pool of the China Cultural Research Association for Traditional Chinese Medicine’s Prevention of Chronic Diseases. He was awarded the title of “Expert in Classic Prescriptions” at the Eighth Nanyang Forum of the Zhang Zhongjing Medical Division of the China Research Promotion Association in 2020. In 2023, he won the Excellence Award in the First Beijing-Tianjin-Hebei “Bian Que Cup” Yan-Zhao Medical Research Theme Essay Competition. His achievements have been featured in the magazines “Contemporary Scientists” and “China’s Elite”.
